Search

Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.

… Wednesday, July 1, 2009 Summary Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist. Jennifer A. Zallen , a member of the Developmental Biology Program in the Sloan

Read about a first-of-its kind PhD program that enables aspiring scientists to tackle tough cancer problems.

… Monday, June 10, 2024 It’s the power of serendipity. In science, great ideas often come from chance encounters between two experts from different worlds. That’s what happened one afternoon a few years ago in the lobby of the Zuckerman Research Center , the 23-story home to lab researchers at Memorial

Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.

… Wednesday, November 3, 2021 Man in surgical scrubs looks at reader Aymar Borel Soh Fotso (Dr. Soh) is an anesthesiologist at Memorial Sloan Kettering Cancer Center. Scroll right for more photos » Borel Soh, Louis Voigt, and Kathryn Martin Dr. Soh (left) at a gala with two of his MSK mentors, Louis Voigt

Gerstner Sloan Kettering student Jessica Rios-Esteves has been awarded the Chairman’s Prize for her first-author paper published in Cell Reports in 2013.

… Wednesday, August 13, 2014 Gerstner Sloan Kettering student Jessica Rios-Esteves has been awarded the Chairman’s Prize for her first-author paper Stearoyl CoA Desaturase Is  Required to Produce Active, Lipid-Modified Wnt Proteins , published in Cell Reports in 2013. Jessica successfully defended her

Learn more about how MSK helps international patients like Annabel Gutherz, a 25-year-old singer from Montreal who sought MSK's expertise in head and neck cancer and found comfort and support far from home.

… Monday, April 7, 2025 There are good reasons for optimism today when the diagnosis is thyroid cancer. At Memorial Sloan Kettering Cancer Center (MSK), most  thyroid cancer treatments — which can include surgery, drugs, or both — are successful, and the overall  survival rates are more than 95%. But when

Memorial Sloan Kettering researchers have discovered that the AR and PI3K disease pathways regulate each other through reciprocal negative feedback.

… Friday, July 1, 2011 Summary Memorial Sloan Kettering researchers have discovered that the AR and PI3K disease pathways regulate each other through reciprocal negative feedback. Prostate cancer is difficult to control once it spreads beyond the initial tumor to other parts of the body. The standard treatment

Detecting a protein in a blood sample could help doctors make treatment decisions for prostate cancer patients.

… Friday, June 29, 2018 Summary A study shows that a blood test that detects a protein called AR-V7 in circulating tumor cells accurately predicts how well certain people with prostate cancer will respond to drugs called AR inhibitors. Doctors can use this test to make decisions about whether these patients

Performing minimally invasive robotic cystectomy and bladder reconstruction in one operation provides a viable alternative to open surgery with less blood loss, decreased pain, diminished wound morbidity, and the potential for faster return of bowel function.

… Friday, November 10, 2017 Performing minimally invasive robotic cystectomy and bladder reconstruction in one operation provides a viable alternative, while maintaining the oncologic standards of the open approach. Some of the benefits appear to be less blood loss, decreased pain, and potentially less

Learn about a new CAR T cell treatment option for multiple myeloma that could work after other therapies have failed.

… Wednesday, September 28, 2022 Multiple myeloma Multiple myeloma , a rare blood cancer, now has many treatment options.   A new CAR T cell therapy CAR T cell therapy targeting an antigen called GPRC5D appears to be safe and effective. For people with multiple myeloma, prognosis has improved considerably

QUEENS, NY, January 17, 2007 - The Queens Library HealthLink initiative was developed to place libraries at the center of an innovative new effort designed to help medically underserved communities throughout Queens access free cancer information, early detection screenings, cancer treatment resources, and other life-saving services.

… Wednesday, January 17, 2007 Five-Year Initiative Will Help Increase Access to Cancer Screenings and Care Among Medically Underserved Communities In Queens In 2007, the American Cancer Society estimates that in the borough of Queens, 182 people will be diagnosed with cancer each week and 68 people will